polatuzumab vedotin,vedolizumab
takeda,roche
['polatuzumab', ' vedo']
. dr. matthew matasar ( ) &amp; colleagues present polatuzumab vedotin combined with r-ice (polar-ice) as second-line therapy... at #ash22. 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.